Volume 29, Issue 2 pp. 124-134

Individualized Selection of Pacing Algorithms for the Prevention of Recurrent Atrial Fibrillation: Results from the VIP Registry

THORSTEN LEWALTER

THORSTEN LEWALTER

Department of Cardiology, University of Bonn, Bonn, Germany

Search for more papers by this author
ALEXANDER YANG

ALEXANDER YANG

Department of Cardiology, University of Bonn, Bonn, Germany

Search for more papers by this author
DIETRICH PFEIFFER

DIETRICH PFEIFFER

University Clinic, Leipzig, Germany

Search for more papers by this author
JAAP RUITER

JAAP RUITER

Medical Centre Alkmaar, Alkmaar, The Netherlands

Search for more papers by this author
GÖTZ SCHNITZLER

GÖTZ SCHNITZLER

St. Vincenz Hospital, Mainz, Germany

Search for more papers by this author
TILMANN MARKERT

TILMANN MARKERT

Heart Centre Coswig, Coswig, Germany

Search for more papers by this author
MOGENS ASKLUND

MOGENS ASKLUND

Kolding Hospital, Denmark

Search for more papers by this author
OLIVER PRZIBILLE

OLIVER PRZIBILLE

University Clinic, Mainz, Germany

Search for more papers by this author
ARMIN WELZ

ARMIN WELZ

Department of Cardiac Surgery, University of Bonn, Bonn, Germany

Search for more papers by this author
BAHMAN ESMAILZADEH

BAHMAN ESMAILZADEH

Department of Cardiac Surgery, University of Bonn, Bonn, Germany

Search for more papers by this author
MARKUS LINHART

MARKUS LINHART

Department of Cardiology, University of Bonn, Bonn, Germany

Search for more papers by this author
BERNDT LÜDERITZ

BERNDT LÜDERITZ

Department of Cardiology, University of Bonn, Bonn, Germany

Search for more papers by this author
First published: 20 February 2006
Citations: 31
Address for reprints: Thorsten Lewalter, M.D., University of Bonn, Sigmund-Freud-str. 25, 53105 Bonn, Germany. Fax: +49 2282-874983; e-mail: [email protected]

Abstract

Objectives: The VIP registry investigated the efficacy of preventive pacing algorithm selection in reducing atrial fibrillation (AF) burden.

Background: There are few data identifying which patients might benefit most from which preventive pacing algorithms.

Methods: Patients, with at least one documented AF episode and a conventional antibradycardia indication for pacemaker therapy, were enrolled. They received pacemakers with AF diagnostics and four preventive algorithms (Selection and PreventAF series, Vitatron). A 3-month Diagnostic Phase with conventional pacing identified a Substrate Group (>70% of AF episodes with <2 premature atrial contractions [PACs] before AF onset) and a Trigger Group (≤70% of AF episodes with <2 PACs before AF onset). This was followed by a 3-month Therapeutic Phase where in the Trigger Group algorithms were enabled aimed at avoiding or preventing a PAC and in the Substrate Group continuous atrial overdrive pacing was enabled.

Results: One hundred and twenty-six patients were evaluated. In the Trigger Group (n = 73), there was a statistically significant 28% improvement in AF burden (median AF burden: 2.06 hours/day, Diagnostic Phase vs 1.49 hours/day, Therapy Phase; P = 0.03304 signed-rank test), and reduced PAC activity. There was no significant improvement in AF burden in the Substrate Group (median AF burden: 1.82 hours/day, Diagnostic Phase vs 2.38 hours/day, Therapy Phase; P = 0.12095 signed-rank test), and little change in PAC activity.

Conclusions: We identified a subgroup of patients for whom the selection of appropriate pacing algorithms, based on individual diagnostic data, translated into a reduced AF burden. Trigger AF patients were more likely responders to preventive pacing algorithms as a result of PAC suppression.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.